Poongjeon Pharmacy rights offering: 1,200,000 new shares, ₩3.0bn

Poongjeon Pharmacy · KOSDAQ · 298060 · Oct 26, 2026 · Rights offerings

Poongjeon Pharmacy filed a rights offering for 1,200,000 new shares, equal to 12.5% of existing shares by our calculation, with an issue amount of ₩3.0bn. The allocation method is third-party allotment and the main purpose of the funds is operating funds. The issue amount equals 12.6% of FY2025 revenue by our calculation.

Key facts

New shares1,200,000 shares
New shares as % of existing shares (calculated)12.5%
Issue amount₩3.0bn
Main purpose of fundsOperating funds
Allocation methodThird-party allotment

Comparison

Amount as % of FY2025 revenue (calculated)12.6%
Revenue 2025₩23.8bn
Revenue 2024₩825m
Revenue 2023₩696m

Context

In the 12 months before this filing, the company issued ₩2.0bn in CB/BW/EB across 1 issue and 796,812 shares in rights offerings.

Key metrics

Potential dilution

CB/BW/EB issued, last 12 months₩2.0bn As of Jun 10, 2026 Source 1 ↗
Rights offering new shares, last 12 months1,996,812 shares As of Oct 26, 2026 Source 1 ↗, Source 2
Potential new shares, last 12 months4,463,078 shares (1 upward conversion price adjustment not netted) As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4 ↗, Source 5 ↗ +1 more
Potential new shares, % of shares46.3% (1 upward conversion price adjustment not netted) As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4 ↗, Source 5 ↗ +2 more
Conversion price adjustments, last 12 months4 As of Aug 4, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)